Review Article

An Overview of Systematic Reviews of Using Chinese Medicine to Treat Polycystic Ovary Syndrome

Table 6

GRADE quality-of-evidence ratings for efficiency.

Included systematic reviewsNumber of studies includedEfficiency effect (95% CI)GRADE quality of evidenceRelegation factors

Yan Lun et al. 2015 [17]14OR = 5.32, 95% CI (3.82, 7.41)Low①④
Xiao Chao 2016 [18]7RR = 1.27, 95% CI (1.19, 1.36)Low①⑤
Li Nan et al. 2017 [19]8OR = 3.90, 95% CI (2.92, 5.20)Low①④
Lu RuLing et al. 2018 [20]11OR = 4.22, 95% CI (2.86, 6.23)Very low①④⑤
Xu LiFang et al. 2018 [21]18OR = 2.83, 95% CI (2.06, 3.88)Very low①④⑤
Xu Huayun et al. 2018 [22]13RR = 1.19, 95% CI (0.87, 1.63)Low①⑤
Huang Wenfang et al. 2018 [23]7OR = 2.63, 95% CI (1.67, 4.15)Very low①④⑤
Ji Lin 2019 [24]21OR = 3.38, 95% CI (2.59, 4.41)Moderate
Xie Peng Peng et al 2019 [27]14RR = 1.13, 95% CI (1.02, 1.24)Moderate
ZhongYizheng et al. 2019 [28]10RR = 1.27, 95% CI (1.13, 1.44)Moderate
Dong YuFang 2020 [29]31RR = 1.26, 95% CI (1.20, 1.32)Moderate
Li Nan et al. 2020 [30]4OR = 3.42, 95% CI (1.76, 6.64)Very low①④⑤
Lin BeiBei 2020 [32]18RR = 1.26, 95% CI (1.17, 1.36)Very low①②④
Chen JinMing et al. 2020 [33]6RR = 1.26, 95% CI (1.15, 1.37)Low①④
Huang Ting et al. 2020 [34]8RR = 1.25, 95% CI (1.13, 1.37)Very low①④⑤

Note. CI: confidence interval; OR: odds ratio; RR: relative risk; ①: limitation; ②: inconsistency; ③: indirectness; ④: publication bias; ⑤: imprecision.